Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Sales (2018 - 2025)

Exagen (XGN) has disclosed Return on Sales for 8 consecutive years, with 0.38% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 10.0% year-over-year to 0.38%, compared with a TTM value of 0.32% through Dec 2025, down 5.0%, and an annual FY2025 reading of 0.3%, down 3.0% over the prior year.
  • Return on Sales was 0.38% for Q4 2025 at Exagen, up from 0.41% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.2% in Q2 2024 and bottomed at 1.93% in Q2 2022.
  • Average Return on Sales over 5 years is 0.56%, with a median of 0.41% recorded in 2023.
  • The sharpest move saw Return on Sales crashed -143bps in 2022, then soared 157bps in 2023.
  • Year by year, Return on Sales stood at 0.56% in 2021, then plummeted by -112bps to 1.18% in 2022, then surged by 66bps to 0.4% in 2023, then skyrocketed by 32bps to 0.27% in 2024, then tumbled by -37bps to 0.38% in 2025.
  • Business Quant data shows Return on Sales for XGN at 0.38% in Q4 2025, 0.41% in Q3 2025, and 0.26% in Q2 2025.